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ABSTRACT 
Objective: Area Under Curve method (AUC) and the Multiple Wavelength Spectrophotometric (MWS) method are practice and simple methods for 
simultaneous assays of Metformin HCl and Glibenclamide on the tablet dosage form.  
Methods: The AUC method is measured for the absorption spectrum with a concentration 4 mg/l Metformin HCl by calculating the area spectrum at 
wavelength 230-240 nm and the absorption spectrum with a concentration 8.7 mg/l
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Results: The validation test of the AUC method for Metformin HCl obtained accuracy = 99.35%, linearity = 0.9881, precision = 0.39%, LOD = 
0.4459 mg/l. LOQ = 1.4864 mg/l
Glibenclamide by calculating the area at wavelength 225-235 
nm. The MWS by determining the absorption spectrum and the five wavelength points for the absorption value at 225 nm, 229.4 nm, 236.6 nm, 233 
nm, and 243 nm and calculated using matrix operations. 
 and for Glibenclamide obtained accuracy = 100.79%, linearity = 0.9993, precision = 0.65%, LOD=0.4372 mg/l, LOQ 
= 1.4072 mg/l and the MWS method for Metformin HCl obtained accuracy = 100.76%, linearity 0.9949,  precision = 0.65%, LOD = 0.9103 mg/l, LOQ 
= 3.0431 mg/l, and for Glibenclamide with accuracy = 100.07%, linearity = 0.9993. precision = 0.36%, LOD = 0.9205 mg/l. LOQ = 3.0431 mg/l 
Keywords: AUC, Glibenclamide, Metformin HCl, MWS, Spectrophotometry methods, Validation  
, 
and appropriate the requirements of ICH guidelines. 
Conclusion: These Methods successively applied to determine of Metformin HCl and Glibenclamide mixture in tablet dosage form and fulfill the 
validation requirements. 




The combination of Metformin HCl (MFM) and Glibenclamide (GBC) 
is widely used as an antidiabetic drug. MFM is a hypoglycemic group 
for reduces glucose production in the liver and increases muscle 
tissue sensitivity and adipose to insulin. The GBC is a hypoglycemic 
drug and a group of Sulfonylureas and works to stimulate insulin 
secretion from pancreatic Langerhans β cell granules. The 
combination of MFM and GBC will make absorption ability of GBC is 
increased because the stimulation of insulin secretion by GBC in 
response to a meal is essential [1, 2]. 
Determination of MFM and GBC levels in a single form can be carried 
out by the ultraviolet spectrophotometry method, MFM has 
maximum absorption at 236 nm and 229 nm for GBC and also can be 
determined by HPLC methods [3, 4]. The method of simultaneous 
determination of MFM and GBC with the HPLC method was 
published in the article using the mobile phase consisting of a 
mixture of 20 mmol ammonium buffer format at pH 3.5 and 
acetonitrile, with a ratio of 45:55 v/v. [5]. 
Various studies on the development of Spectrophotometry methods 
have been published as examples: UV spectrophotometry methods 
for simultaneous estimation, Double Divisor Spectra derivative 
spectrophotometry ratio, and MCR method [6-9]. 
Some researchers have made a simultaneous determination of MFM 
and GBC mixture of development of spectrophotometry methods 
such as a derivative spectrophotometry method, simultaneous 
equation. The discovery of new course spectrophotometry methods 
has been validated and appropriate requirements of ICH guidelines 
and can leave the classic spectrophotometry method for multi-
component analysis of drug [10-13]. 
The AUC method is a simple, economical, and relatively faster way 
that has also been developed. Research conducted by Ilango and 
Kumar (2012) for the determination of Medoxomil and 
Hydrochlorothiazide levels, and Karajgi's research, et al. (2016) for 
simultaneous determination of Artemether and Lumefantrine levels 
in drug preparations provided accurate, precise and selective 
results. The Area Under Curve method in spectrophotometry was 
carried out and offered exact, and particular [14-17]. 
The MWS methods are a spectrophotometry method for the 
simultaneous determination of the drug mixture by determining the 
absorption point at various wavelengths whose absorption curves 
have overlapped and the level calculations performed by a matrix 
operation [18]. 
The AUC method is a spectrophotometry method which 
simultaneously determines MFM and GBC overlapping absorption 
curves between MFM and GBC, whose absorption measurements are 
not at maximum absorption, but used in areas that have no 
maximum spectrum curve but which are carried out in a parabolic 
spectrum area. This method has a value at two selected wavelengths, 
λ1 and λ2. The obtained AUC value is determined by the levels of 
each drug in the regression equation [14-17]. The MWS 
spectrophotometry method has a procedure to determine the five 
points on the overlapped absorption curves of the MFM and GBC are 
used together, then the absorption is determined and calculated by 
the matrix equation [18]. 
The aims of this research are to validation and simultaneous assays 
of AUC and MWS methods for simultaneous determination of MFM 
and GBC. 
MATERIALS AND METHODS 
Instrumentation and methods 
The U. V. Spectrophotometer (Shimadzu 1800) which combined 
with a set of Personal Computers (P. C. s) equipped with 2.42 UV-
Probe software and software with the Minitab®17 application. 99.8 
% Metformin HCl, 99.4% Glibenclamide from Kimia Farma Plant 
Medan, Sumatera Utara, Indonesia, 100.02% Metformin HCl and 
99.98% Glibenclamide (Indonesian Standard) Methanol absolute 
and 25% NH4OH, E. Merck, German from Rudang Medan Indonesia. 
Local Product of Metformin and Glibenclamide by Sanbe, Bandung, 
Indonesia.  
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Preparation of MFM and GBC working solutions 
The working solutions are prepared by dissolving 50.3 mg MFM and 
50.4 mg GBC powder, transferred to 50 ml volumetric flasks 
respectively and dissolved with methanol absolute, then taken 5 ml 
of MFM and 10 ml of GBC accurately and transferred to 50 ml 
volumetric flasks respectively, then disappeared with methanol pure 
to get 50.3 mg/l MFM and 100.8 mg/l GBC, and both of them used as 
working solutions. 
Preparation absorption spectrum 
The working solution is taken 0.8 ml of MFM and 0.9 ml of GBC 
respectively, and then it's measured at the wavelength of 200-400 nm.  
The validation test 
The validation of these methods was performed based on the U. S. 
Food and Drug Administration (FDA) guidelines for precision, 
accuracy, linearity, the limit of detection (LOD), Limit of Quantitation 
(LOQ), linearity and coefficient of variation are validation parameter 
for spectrophotometry methods [19-21].  
Accuracy 
The accuracy method was determined using the standard addition 
method by preparing a sample with three specific ranges of 80%, 
100%, and 120%, with six repetitions. The formula for accuracy:  
% recovery=  
Note:  
CF = Concentration after addition 
CA = Theoretical concentration before addition 
AC = Concentration of the added standard substances  
Precision 
The calculation of the relative standard deviation (RSD) value is 
used to determine the precision in the validation method. RSD is a 
formula as follows:  
 
Note:  
RSD = Relative standard deviation 
SD = Standard deviation 
X = Average data. 
Linearity 
The linearity of the analytical method in the validation method was 
determined by calculating the correlation coefficient [19-21].  
The regression equation is a formula as follows:  
Y = ax+b 
Notes:  
Y = Absorption 
a = Slope 
x = Concentration (mg/l-1) 
b = Constant. 
Limits of detection (LOD) and limits of quantitative (LOQ)  
According to the absorbance at the analytical wavelength, the LOD 





SD = Standard deviation 
Slope = a (y = ax+b) 
Area under curve method (AUC) 
Construction of absorption spectrum of MFM and GBC 
The working solution is carefully taken at 4.0 mg/l MFM and 8.7 
mg/l GBC concentrations and measured their absorption spectrum 
respectively and used a U. V. probe 2.42 software to calculate the 
area values in the area range 230-240 nm for MFM and 225-
235 nm areas for GBC. The Concentration of Metformin and 




C = Concentration 
X λ1–λ2  = AUC λ1–λ2/Concentration in mg/l-1 
X λ3–λ4  = AUC λ3–λ4/Concentration in mg/l-1 
Construction of calibration curve for the AUC method 
The calibration curve can determine by the value of the area in the 
curve between two selected wavelengths such as λ1 and λ2 (AUC 
value), The AUC value of each spectrum in various concentrations is 
calculated to get the analytical wavelength, then calculated and 
plotted with varying concentrations to obtain the regression line 
equation using U. V. Probe 2.42 software [14, 16]: 
 
Note:  
Y = AUC value 
a = intercept 
b= regression coefficient  
Multiple wavelength spectrophotometry methods 
Construction of spectrum selection point 
The working solution is construction to 4.0 mg/l-1 MFM and 8.7 
mg/l-1 GBC concentrations, and these solution's absorption 
measured at 200-400 nm wavelength. Furthermore, the absorption 
spectrum overlapped Then searches five points as the wavelength to 
use. Wavelength selection is taken from the absorption spectrum of 
components, the absorption measured at predetermined multiple 
wavelengths. Both compound's absorption is determined using the 
matrix equation method, which operated in the concentration and 
absorption data of each compound at each wavelength measurement  
Determination of MFM and GBC absorption curves 
Carefully weighed 4.0 mg MFM (Indonesian Standard) and 8.7 mg of 
GBC (Indonesian Standard) and then transfer into the 10.0 ml flask, 
diluted with methanol to obtain a solution with a concentration of 
4.0 mg/l-1 MFM and of 8.7 mg/l-1 GBC, then the two solutions are 
measured for each at a wavelength of 200-400 nm. Furthermore, the 
two curves are overlapped and determined the five points.  
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Assay procedures for a tablet by AUC and MWS 
Twenty tablets were weighed and finely powdered. The powder 
obtained was sufficiently considered in such a way to contain 50 
mg of MFM and transferred to a 50 ml volumetric flask, dissolved 
with methanol. Then, pipette 0.1 ml sample solution and added 
4.3 ml (433.44 µg) of GBC working solution for standard 
addition.  
The measured absorption spectrum is created in the area of 230-
240 nm for MFM and 235–245 nm for GBC at the AUC method. 
Level calculations are done using the regression equation [14-
17]. 
The MWS methods are the methods for measurement of MFM and 
GBC mixture based on five-point absorption from the overlapping 
curve of raw material. The content of each component in the mix is 
calculated based on the absorption capacity of drug samples (Ac) 
and the absorption value and obtained from measurements of 
predetermined wavelengths, and component levels obtained using a 
matrix equation [18]. 
 
Note:  





= transpose absorption matrix of mixed compounds 
= matrix of the compound mixture absorption 
= matrix inverses multiplied by the transpose 
absorption matrix of compound mixture 
= matrix of sample absorption value 
 
RESULTS AND DISCUSSION 
The principle of development method on U. V. spectro-
photometry 
The Principle of the method of molecular absorption in U. V. 
spectrophotometry has been widely used for the determination of 
drug components in pharmaceutical preparations. This method can 
be used for pharmaceutical analysis, which has a spectrum matrix 
constraint of the active drug, overlapped and making it difficult as 
the simultaneous determination of the drug mixture [3-4]. 
Absorption spectrum of MFM and GBC 
Determination of maximum absorption spectrum of Metformin and 
Glibenclamide was making in the wavelength range of 200-400 nm. 
The results obtained that the qualitative absorption spectrum of 
4.1 mg/l-1 Metformin at the 235.6 nm (fig. 1) and 8.7 mg/l-1
The result from the production of validation test must be achieved for 
chemical analysis activities. The validation test result is described as 
linearity, LOD, LOQ, R
 
Glibenclamide at 228.2 nm (fig. 2). 
The maximum absorption of MFM and GBC at 235.6 nm and 228.2 
nm is qualified because that Moffat (2011) wrote that the maximum 
wavelength of MFM is located at 236 nm, GBC was located at 
225 nm as methanol is a solvent. Based on Indonesian Pharmacopeia 
that the difference in the maximum wavelength of each MFM and 
GBC was no less and no more than 5 nm [3, 4]. It means that the 
maximum wavelength of each component is qualified.  
Validation methods 
2. accuracy, and precision (table 1). 
 
Fig. 1: MFM absorption spectra 
 
 
Fig. 2: GBC absorption spectra 
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Table 1: Validation of the AUC method and MWS method 
 Parameter  MFM GBC 
AUC MWS AUC MWS 
Solvent Methanol  Methanol  
Linearity (%) 0.9881 0.9993 0.9949 0.9987 
LOD (mg/l) 0.4459 0.4372 0.9103 0.9205 
LOQ (mg/l) 1.4864 1.4072 3.0344 3.0431 
R 0.9881 2 0.9993 0.9946 0.9993 
Accuracy(%) 99.35 103.16 100.76. 100.07 
Precision (%) 0.39 0.26% 0.65 0. 
 
It can be stated that the AUC and MWS method have excellent 
accuracy and precision, besides that all carried out measurements 
are in the 0.2–0.6 absorption area which means that the sample 
measurements are also above the detection limit and the 
quantitation limit because all parameters of validation test have 
according to the validation requirements of ICH 2015. It means that 
both of these methods have appropriated the validation 
requirements [15-17]. 
Result of AUC methods and MWS methods for sample 
The spectrum absorption curve of sample for the market 
product 
The curve of the spectrum absorption from a mixed sample of 250 
mg Metformin HCl and 1.25 mg Glibenclamide on market products 




Fig. 3: The curve absorption spectrum of sample from market products 
 
Based on the fig. 3 above, it can be seen that the concentration of 
GBC in the mixture is minimal. Based on the validation method 
for LOQ results of the AUC method has obtained LOQ = 3.0344 
mg/l While the MWS method is LOQ = 3.0431 mg/l and it is true 
that content of GBC in tablets sample containing 50 mg of MFM, 
It’s small below LOQ which is 0.2499 mg. According to the law of 
lambert beer, this naturally produces in a low GBC 
concentration, namely 0.0199 mg/l while the GBC concentration 
is according to the level of MFM. So the GBC working solution 
was added 8.6801 mg/l which total was added 433.44 µg in 50 
ml sample solution. So, using the AUC and MWS methods, the 
content of glowing levels in the sample can be known. 
Overlapped absorption spectrum for AUC method 
The AUC method begins by calculating the AUC value in the spectrum 
in the wavelength range of 227 nm-248 nm with concentrations of 
(2. 3. 4. 5. 6) mg/l for MFM and wavelength range 225 nm-236 nm 
with a level of (4.7. 6.7. 8.7. 10.7. 12.7) mg/l 
Component 
for GBC the range of λ 
(wavelength) selected to give the best linearity relationship between 
the AUC and Concentration (fig. 4) as indicated by the value of the 
correlation coefficient (r ≤ 1)and can be seen at table 2 [15, 16]. 
 
Table 2: Wavelength of analysis for metformin and glibenclamide 
Wavelength (nm) Δλ Linierity 
Metformin G227-231 5 0.9688 
234-238 5 0.9797 
230-240 10 0.9881 
231-241 10 0.9880 
Glibenclamide 227-231 5 0.9757 
228-232 5 0.9934 
225-235 10 0.9949 
226-236 10 0.9934 
 
Based on table 2 shows that the excellent wavelength range is (230-
240) nm for GBC have a good the value of the correlation coefficient, 
so the selected wavelengths to determine MFM and GBC by 
spectrophotometry UV with AUC method were 230-240 nm and 
225-235 nm, respectively. It concludes that there is no overlapping 
AUC of each wavelength ranges both for MFM (230-240) nm and 
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GBC (225-235) nm and affecting one to another. The absorption 
value that appropriates the requirements is obtained with the 
wavelength range. That's mean AUC method can be used to 
determine simultaneously the drug content, which consisting of 
more than one component [15, 17]. 
The determination of the AUC in the tablet market production is 
carried wavelength (230-240) nm for MFM and (225-235) nm for 




C = Concentration 
X λ1–λ2  = AUC λ1–λ2/Concentration in mg/l
X 
-1 
λ3–λ4  = AUC λ3–λ4/Concentration in mg/l
Based on the calculation above, the AUC values are obtained, which 
result in table 3 for MFM and table 4 for GBC below. 
 
Table 3: AUC value of MFM 
-1 
No. Concentration (µg/ml) AUC (Y) 
1 0.0000 0.0000 
2 2.0 0.1840 
3 3.0 0.2880 
4 4.0 0.3130 
5 5.0 0.3760 
6 6.0 0.4680 
 
Table 4: AUC value of GBC 
No. Concentration (µg/ml) AUC (Y) 
1 0.0000 0.0000 
2 4.7 0.1170 
3 6.7 0.1850 
4 8.7 0.2430 
5 10.7 0.2930 
6 12.7 0.3860 
Based on the AUC value in table 3 and table 4. then each regression equation can be calculated whose results can be shown in table 5 for MFM and 
table 6 for GBC. 
 
Table 5: Calculation of regression equations on MFM 
No. X Y XY X Y2` 2 
1. 0.0000 0.00000 0.00000 0.00000 0.0000000000 
2. 2.0 0.1840 0.368 4 0.033856 
3. 3.0 0.2880 0.864 9 0.082944 
4. 4.0 0.3130 1.252 16 0.097969 
5. 5.0 0.3760 1.88 25 0.141376 
6. 6.0 0.4680 2.808 36 0.219024 
 ΣX = 20 
 = 3.3333 
ΣY = 1.629 
 = 0.2715 
ΣXY = 1.1953 ΣX2 Σ Y = 90 2 = 0.575169 
 
Table 6: Calculation of regression equations on GBG 
No. X Y XY X Y2` 2 
1. 0.0000 0.00000 0.00000 0.00000 0.0000000000 
2. 4.7 0.1170 0.5499 22.0900 0.013689 
3. 6.7 0.1850 1.2395 44.8900 0.034225 
4. 8.7 0.2430 2.1141 75.6900 0.059049 
5. 10.7 0.2930 3.1351 114.4900 0.085849 
6. 12.7 0.3860 4.9022 161.2900 0.148996 
 ΣX = 43.5 
 = 7.25 
ΣY = 1.224 
 = 0.204 
ΣXY = 11.9407 ΣX2 Σ Y = 418.45 2 = 0.341808 
 
Baesd on table 5 and table 6 can be calculated the regression 
equation by formula (19) 
 
Note:  
Y = AUC value 
a = intercept 
b= regression coefficient  
Based on calculations from the above formula, the regression 
equation for MFM and GBC is obtained y = 0.074 x+0.022 and y = 
0.029 x-0.011. The calculation of the sample is carried out with 
replications six times followed by statistical calculations so that 
the average level is obtained in table 7, table 8 and table 9. 
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Table 7: The metformin HCl levels on the market product samples 
No Weight of MFM in the sample (mg) Weight of the study results (mg) Percentage of measure result (%) 
1 50.06 51.12 101.37% 
2 50.09 52.00 103.05% 
3 50.11 52.12 103.24% 
4 50.12 52.25 103.47% 
5 50.14 52.75 104.40% 
6 50.15 52.62 104.10% 
 
Table 8: The glibenclamide levels on the market product samples 
No Weight of GBC in the sample 
(mg) 
Addition weights of raw GBC to the 
sample (mg) 
Weight of the study results 
(mg) 
Percentage of measure 
result (%) 
1 0.2498 108.50 108.75 99.04% 
2 0.2505 108.62 108.87 97.06% 
3 0.2507 108.50 109.00 96.11% 
4 0.2511 108.50 108.75 98.06% 
5 0.2515 108.62 108.87 99.39% 
6 0.2526 108.62 108.87 98.46% 
 
Table 9: Statistical calculation of MFM and GBC on the market product 
No Component of drug Statistical calculation Content in etiquette Level requirements 
1 MFM (103.27±1.7521)% 250 mg (95–105)% 
2 GBC (98.02±2.0404)% 1.25 mg (95-105)% 
 
Based on table 9 above, after statistical calculation of MFM and GBC in 
the market production mixture, the levels were (103.27±1.7521)% for 
MFM and (98.02±2.0404)% for GBC to meet the requirements for tablet 
dosage according to Indonesian Pharmacopoeia Edition V is (95-105)%. 
It means that the AUC method can be used to simultaneous determine 
the mixture of MFM and GBC in a tablet. 
Result of five absorption points for MWS methods 
The simultaneous determination of MFM and GBC is combined of 
two spectra, to make a five of wavelength points (for analysis of 
MFM and GBC mixture). The five used to measure the absorption of 
each standard solution MFM and GBC was obtained (fig. 4). 
  
 
Fig. 4: Five-wavelength analysis used in the multiple wavelengths method 
 
After measuring the absorption of each solution by various 
concentrations at the five wavelengths are obtained that five 
wavelengths used is 225 nm, at a wavelength of MFM and GBC have 
begun to provide absorption. The wavelength of 229.4 is the 
maximum absorption GBC, and wavelength of 233 nm is the point of 
intersection of MFM and GBC, the wavelength of 236.6 nm is the 
maximum wavelength of MFM, and a wavelength of 243 nm, either 
MFM or GBC absorption begins to decrease. The obtained absorption 
data is used to establish the levels of MFM and GBC in the mixture 
with matrix calculation.  
Results of determination of absorption at five wavelengths 
Absorption value is the ability of the absorption of a compound to 
absorb from a mixture of compounds at the selected wavelength. 
The determination of the absorption value is done by measuring the 
absorption of each solution of MFM and GBC at a wavelength of 225 
nm; 229.4 nm; 233 nm; 236.6 nm; and 243 nm. The measurements 
result of MFM and GBC uptake can be seen in table 10. 
The selection of absorption values (a) can be determined based on the 
calculated r-value. The estimated r-value is compared with the r-value of 
the table with a confidence level of 95% with df four, which is 0.8114. 
Based on table 10 and table 11 above, the value of r count metformin and 
glibenclamide are higher than the value of r table. It means that the 
equation has excellent linearity because the value of r count is ≤1. 
Simultaneous determination results of MFM and GBC with the 
MWS method 
The market preparations contain MFM 250 mg and GBC 1.25 mg. With a 
ratio of 1: 200 so that the GBC level is challenging to analyze. To 
overcome this, add the GBC working solution so that measurements can 
be made with six repetitions, with the aim that the data obtained is more 
accurate. Then the absorption is measured at the five wavelengths of 225 
nm; 229.4 nm; 233 nm; 236.6 nm and 243 nm. The absorption data of 
the mixed samples of MFM and GBC samples were obtained, then carried 
out by calculating the matrix so that the level and percentage of the 
coefficient of variation can be seen in table 12 below. 
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0.0 0.0000 0.0000 0.0000 0.00000 0.0000 
2 0.1268 0.1834 0.2278 0.24738 0.1936 
3 0.1904 0.2600 0.3140 0.34029 0.2742 
4 0.2118 0.3167 0.4017 0.44580 0.3586\ 
5 0.2788 0.4054 0.5092 0.56339 0.4579 
6 0.3338 0.4877 0.6142 0.67867 0.5494 
 a= 0.062 a= 0.084 a= 0.101 a= 0.110 a=0.075 
r= 0.9995 r= 0.9981 r= 0.9990 r= 0.9993 r= 0.9996 
 













0.0 0.0000 0.0000 0.0000 0.0000 0.0000 
4.7 0.2385 0.2448 0.2290 0.1927 0.1199 
6,7 0.3290 0.3420 0.3220 0.2713 0.1661 
8.7 0.4416 0.4483 0.4180 0.3521 0.2207 
10.7 0.5146 0.5351 0.5036 0.4259 0.2664 
12,7 0.6384 0.6669 0.6281 0.5291 0.3219 
 a= 0.052 a= 0.051 a= 0.041 a= 0.048 a= 0.020 
r= 0.9991 r= 0.9992 r= 0.9992 r= 0.9993 r= 0.9997 
 


























4.07517 4.0054 100.99 8.70025 0.02 100.24 
4.22861 4.0183 104.46 8.70033 0.02 100.63 
4.23732 4.0247 104.51 8.70097 0.02 103.84 
4.24082 4.0248 104.59 8.70018 0.02 99.90 
4.04323 4.0377 99.40 8.69972 0.02 97.61 
4.22542 3.9924 105.06 8.66894 0.02 98.24 
 Average 103.16 Average 100.07 
 Coefficient of variation (%) 0.2628 Coefficient of variation (%) 0.3641 
 
Based on table 12 above, that MFM and GBC levels in market 
products meet the requirements according to Indonesian 
Pharmacopoeia Edition V (2014), namely for tablet preparations 
containing MFM and GBC not less than 90% and no more than 110% 
of the amount indicated on etiquette. It means that the MWS method 
can be used for simultaneous determination of MFM and GBC.  
The result of the application of AUC and MWS methods for MFM 
and GBC 
The result of simultaneous determination from the MWS method 
and the AUC method for MFM and GBC levels has been 
calculated (table 2). 
 
Table 2: Statistic calculation of MFM and GBC in mixture formula 
Component AUC MWS 
MFM GBC MFM GBC 
Self-made Product (%)
 100.38±0.97 100.23±1.52 100.02±0.29 98.28±1.78 
Local Product (%) 103.27 98.02 103.16 100.07 
Coefficient Variation (%) 1.75 2.04 0.26 0.36 
Range of Level (%) 90-110 90-110 90-110 90-110 
 
The result of the statistical calculation of this method was not 
significant, although with a different work procedure. Both ways have 
given MFM and GBC levels in laboratory self-made and local products, 
and it's appropriate the requirements according to Indonesian 
Pharmacopoeia edition V (2014). It means that AUC methods and 
MWS methods have good accuracy because they are in the range of 
90%-110% and also have excellent precision because the percentage 
of coefficient variation of MFM and GBC are<2% [15-17]. 
CONCLUSION 
The Area Under Curve method and Multiple Wavelength method can 
simultaneous assays of Metformin and Glibenclamide mixture in 
methanol solvent with overlapping spectra, and have a functional 
recovery and accuracy makes them applicable in quality control 
laboratories and were validated according to ICH guidelines for 
simultaneous assays of Metformin and Glibenclamide in laboratory 
self-made and local Product. 
Therefore the Area Under Curve method and Multiple Wavelength 
methods have successfully applied the simultaneous determination 
of Metformin and Glibenclamide on the pharmaceutical formulation.  
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